Daniel H. Caignard

650 total citations
31 papers, 517 citations indexed

About

Daniel H. Caignard is a scholar working on Organic Chemistry, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Daniel H. Caignard has authored 31 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 12 papers in Molecular Biology and 7 papers in Endocrine and Autonomic Systems. Recurrent topics in Daniel H. Caignard's work include Circadian rhythm and melatonin (7 papers), Free Radicals and Antioxidants (5 papers) and Synthesis of Organic Compounds (5 papers). Daniel H. Caignard is often cited by papers focused on Circadian rhythm and melatonin (7 papers), Free Radicals and Antioxidants (5 papers) and Synthesis of Organic Compounds (5 papers). Daniel H. Caignard collaborates with scholars based in France, Spain and Greece. Daniel H. Caignard's co-authors include Stéphane Léonce, Saı̈d Yous, Philippe Delagrange, Pierre Renard, Ghanem Atassi, Almudena Bermejo, Diego Cortés, Nuria Cabedo, Pierre‐Yves Renard and María Dolors Pujol and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Daniel H. Caignard

31 papers receiving 503 citations

Peers

Countries citing papers authored by Daniel H. Caignard

Since Specialization

Citations

This map shows the geographic impact of Daniel H. Caignard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Caignard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Caignard more than expected).

Fields of papers citing papers by Daniel H. Caignard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Caignard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Caignard. The network helps show where Daniel H. Caignard may publish in the future.

Co-authorship network of co-authors of Daniel H. Caignard

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel H. Caignard. A scholar is included among the top collaborators of Daniel H. Caignard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel H. Caignard. Daniel H. Caignard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Daniel H. Caignard, Philippe Delagrange, Patricia Melnyk, Saı̈d Yous	12
2	Synthesis of benzopyran derivatives as PPARα and/or PPARγ activators 2019 ·Bioorganic & Medicinal Chemistry ·Almudena Bermejo, Isabel Barrachina, Noureddine El Aouad, Xavier Franck, (unknown), Inmaculada Andreu, Bruno Figadère, (unknown), Nathalie Hennuyer, Bart Staels, Catherine Dacquet, Daniel H. Caignard, María‐Jesús Sanz, Diego Cortés, Nuria Cabedo	10
3	Substituted tetrahydroisoquinolines: synthesis, characterization, antitumor activity and other biological properties 2018 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Laura Grau, (unknown), J. Rubio, Daniel H. Caignard, María Dolors Pujol	15
4	Synthesis and Structure–Affinity Relationships of Selective High-Affinity 5-HT₄Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers 2012 ·Journal of Medicinal Chemistry ·Emmanuelle Dubost⧫, (unknown), Christine Fossey, (unknown), (unknown), Céline Ballandonne, Daniel H. Caignard, Fabienne Dulin, (unknown), P. Millet, Yves Charnay, Sylvain Rault, Thomas Cailly, Frédéric Fabis	83
5	Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·Matthieu Jeanty, Franck Suzenet, Philippe Delagrange, Olivier Nosjean, Jean A. Boutin, Daniel H. Caignard, Gérald Guillaumet	12
6	Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands 2011 ·European Journal of Medicinal Chemistry ·Christophe Mésangeau, (unknown), Philippe Delagrange, Daniel H. Caignard, Jean A. Boutin, Pascal Berthelot, Saı̈d Yous	19
7	Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT1 melatoninergic ligands 2010 ·Bioorganic & Medicinal Chemistry ·Christophe Mésangeau, Basile Pérès, (unknown), Philippe Chavatte, Valérie Audinot, (unknown), Jean A. Boutin, Philippe Delagrange, Caroline Bennejean, Pierre Renard, Daniel H. Caignard, Pascal Berthelot, Saı̈d Yous	23
8	Synthesis of new 8(S)-HETE analogs and their biological evaluation as activators of the PPAR nuclear receptors 2010 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), Fréderic Caïjo, Anne‐Lise Girard, (unknown), Valérie Audinot, Jean A. Boutin, Pierre Renard, Daniel H. Caignard, Catherine Dacquet, Alain Ktorza, Paul Mosset, René Grée	2
9	Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II 2009 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), Valérie Audinot, (unknown), Jean A. Boutin, Philippe Delagrange, Daniel H. Caignard, Caroline Bennejean, Pierre Renard, Daniel Lesieur, Pascal Berthelot, Saı̈d Yous	18
10	Synthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands 2008 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Basile Pérès, Jean A. Boutin, Valérie Audinot, Caroline Bennejean, Philippe Delagrange, Daniel H. Caignard, Pierre Renard, Pascal Berthelot, Daniel Lesieur, Saı̈d Yous	24
11	Synthesis and Cytotoxic Activity of pyridazino[1′,6′:1,2]pyrido[3,4-b]indol-5-inium derivatives as anti-cancer agents 2002 ·Bioorganic & Medicinal Chemistry Letters ·Alberto Fontana, (unknown), (unknown), Nuria Sánchez-López, Ramón Alajarı́n, Juan J. Vaquero, Julio Álvarez‐Buílla, (unknown), Stéphane Léonce, Alain St. Pierre, Daniel H. Caignard	8
12	Syntheses and Antitumor Targeting G1 Phase of the Cell Cycle of Benzoyldihydroisoquinolines and Related 1-Substituted Isoquinolines 2002 ·Journal of Medicinal Chemistry ·Almudena Bermejo, Inmaculada Andreu, Fernando D. Suvire, Stéphane Léonce, Daniel H. Caignard, Pierre Renard, Alain St. Pierre, Ricardo D. Enriz, Diego Cortés, Nuria Cabedo	51
13	An efficient method for the preparation of antitumoral α-keto-imines benzyldihydroisoquinolines by selective benzylic oxidation with C/Pd in acetonitrile 2002 ·Tetrahedron Letters ·Inmaculada Andreu, Nuria Cabedo, Ghanem Atassi, Alain St. Pierre, Daniel H. Caignard, Pierre Renard, Diego Cortés, Almudena Bermejo	8
14	Synthesis and cytotoxic activity of 2-dialkylaminoethylamino substituted xanthenone and thioxanthenone derivatives 2000 ·Il Farmaco ·Ioannis K. Kostakis, (unknown), Nicole Pouli, Panagiotis Marakos, Alexios‐Léandros Skaltsounis, Stéphane Léonce, Daniel H. Caignard, Ghanem Atassi	20
15	Synthesis and Conformational Analysis of Some New Pyrano[2,3-c]xanthen-7-one and Pyrano[3,2-b]xanthen-6-one Derivatives with Cytotoxic Activity 2000 ·Heterocycles ·Panagiotis Marakos, (unknown), Nicole Pouli, Alexios‐Léandros Skaltsounis, Stéphane Léonce, Daniel H. Caignard, Ghanem Atassi	20
16	Semisynthesis and Cytotoxicity of Styryl-Lactone Derivatives 1999 ·Journal of Natural Products ·Almudena Bermejo, Stéphane Léonce, Nuria Cabedo, Inmaculada Andreu, Daniel H. Caignard, Ghanem Atassi, Diego Cortés	24
17	Substituted pyrido[3,2-b]oxazin-3(4H)-ones: synthesis and evaluation of antinociceptive activity 1998 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Daniel H. Caignard, Bruno Pfeiffer, Pierre‐Yves Renard, M.C. Viaud, Gérald Guillaumet	11
18	Synthesis and Biological Evaluation of New 3-Aralkylamino-2-aryl-2H-1,2,4-pyridothiadiazine 1,1-dioxides as Potential CCK-Receptor Ligands 1997 ·Journal of Pharmacy and Pharmacology ·Pascal De Tullio, Bernard Pirotte, P. Neven, Bernard Masereel, (unknown), Ousmane Diouf, Tchao Podona, Daniel H. Caignard, Pierre Renard, J. Delarge	3
19	Effects of S20787 on pHi-Regulating Mechanisms in Isolated Rat Ventricular Myocytes 1996 ·Journal of Cardiovascular Pharmacology ·Dominique Lagadic‐Gossmann, (unknown), Guillaume Le Baut, Daniel H. Caignard, Patricia Renard, Elizabeth Scalbert, D. Feuvray	5
20	ChemInform Abstract: Synthesis and Biological Activity of Conformationally Restricted Tricyclic Analogues of the Hormone Melatonin 1996 ·ChemInform ·(unknown), Patrick Depreux, Daniel Lesieur, Daniel H. Caignard, Pierre‐Yves Renard, Philippe Delagrange, Béatrice Guardiola‐Lemaître, Peter J. Morgan	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact